Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017

Weiliang Wu, Jinxian He, Xiaobo Shao, Weiliang Wu, Jinxian He, Xiaobo Shao

Abstract

Congenital heart disease (CHD) is the most commonly diagnosed congenital disorder in newborns. The incidence and mortality of CHD vary worldwide. A detailed understanding of the global, regional, and national distribution of CHD is critical for CHD prevention.We collected the incidence and mortality data of CHD from the Global Burden of Disease study 2017 database. Average annual percentage change was applied to quantify the temporal trends of CHD incidence and mortality at the global, regional, and national level, 1990-2017. A sociodemographic index (SDI) was created for each location based on income per capita, educational attainment, and fertility.The incidence of CHD was relatively high in developing countries located in Africa and Asia, while low in most developed countries. Between 1990 and 2017, the CHD incidence rate remained stable at the global level, whereas increased in certain developed countries, such as Germany and France. The age-standardized mortality rate of CHD declined substantially over the last 3 decades, regardless of sex, age, and SDI region. The decline was more prominent in developed countries. We also detected a significant positive correlation between CHD incidence and CHD mortality in both 1990 and 2017, by SDI.The incidence of CHD remained stable over the last 3 decades, suggesting little improvement in CHD prevention strategies and highlighting the importance of etiological studies. The mortality of CHD decreased worldwide, albeit the greatly geographical heterogeneity. Developing countries located in Africa and Asia deserve more attention and priority in the global CHD prevention program.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram of the study design.
Figure 2
Figure 2
(A, B) The incidence and mortality rate of congenital heart disease between 1990 and 2017, by sex and socio-demographical index (SDI) region.
Figure 3
Figure 3
(A) The incidence rate of congenital heart disease (CHD) by location, in 2017. Rate is per 1000 population. (B) The average annual percentage change (AAPC) of CHD incidence rate by location, between 1990 and 2017. (C) The mortality rate of CHD by location, in 2017. Rate is per 100,000 population. (D) The AAPC of CHD mortality rate by location, between 1990 and 2017.
Figure 4
Figure 4
The association between congenital heart disease (CHD) incidence and CHD mortality. The CHD mortality rates were positively related to the CHD incidence rate in both 1990 and 2017, by socio-demographical index (SDI) region.

References

    1. Bouma BJ, Mulder BJ. Changing landscape of congenital heart disease. Circ Res 2017;120:908–22.
    1. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241–7.
    1. Liu Y, Chen S, Zuhlke L, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019;48:455–63.
    1. van der Bom T, Zomer AC, Zwinderman AH, et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011;8:50–60.
    1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018;392:1736–88.
    1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014;129:399–410.
    1. Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By Alfred Blalock and Helen B. Taussig. JAMA 1984;251:2123–38.
    1. Leirgul E, Fomina T, Brodwall K, et al. Birth prevalence of congenital heart defects in Norway 1994-2009--a nationwide study. Am Heart J 2014;168:956–64.
    1. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018. Available at: .
    1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018;392:1789–858.
    1. Jain NB, Ayers GD, Peterson EN, et al. Traumatic spinal cord injury in the United States, 1993-2012. JAMA 2015;313:2236–43.
    1. Gao S, Yang WS, Bray F, et al. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Eur J Epidemiol 2012;27:39–46.
    1. Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014;130:749–56.
    1. Zaidi S, Brueckner M. Genetics and genomics of congenital heart disease. Circ Res 2017;120:923–40.
    1. Gelb BD, Chung WK. Complex genetics and the etiology of human congenital heart disease. Cold Spring Harb Perspect Med 2014;4:a013953.
    1. Kuciene R, Dulskiene V. Selected environmental risk factors and congenital heart defects. Medicina (Kaunas, Lithuania) 2008;44:827–32.
    1. Simeone RM, Tinker SC, Gilboa SM, et al. Proportion of selected congenital heart defects attributable to recognized risk factors. Ann Epidemiol 2016;26:838–45.
    1. Correa A. Pregestational diabetes mellitus and congenital heart defects. Circulation 2016;133:2219–21.
    1. Engineer A, Saiyin T, Lu X, et al. Sapropterin treatment prevents congenital heart defects induced by pregestational diabetes mellitus in mice. J Am Heart Assoc 2018;7:e009624.
    1. Levy HL. Congenital heart disease in maternal PKU. Mol Genet Metab 2012;107:648–9.
    1. Rouse B, Matalon R, Koch R, et al. Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes. J Pediatr 2000;136:57–61.
    1. Botto LD, Panichello JD, Browne ML, et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol 2014;210:359.e351–11.
    1. Gilboa SM, Desrosiers TA, Lawson C, et al. Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med 2012;69:628–35.
    1. Lazar M, Perelygina L, Martines R, et al. Immunolocalization and distribution of rubella antigen in fatal congenital rubella syndrome. EBioMedicine 2016;3:86–92.
    1. Persson M, Razaz N, Edstedt Bonamy AK, et al. Maternal overweight and obesity and risk of congenital heart defects. J Am Coll Cardiol 2019;73:44–53.
    1. Yang J, Qiu H, Qu P, et al. Prenatal alcohol exposure and congenital heart defects: a meta-analysis. PloS One 2015;10:e0130681.
    1. Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet (London, England) 2012;379:2459–64.
    1. Cox AT, Boos CJ, Sharma S. The Hearts of Heroes: the epidemiology of cardiac disease in the UK Armed Forces. J R Army Med Corps 2015;161:169–72.
    1. Jicinska H, Vlasin P, Jicinsky M, et al. Does first-trimester screening modify the natural history of congenital heart disease? Analysis of outcome of regional cardiac screening at 2 different time periods. Circulation 2017;135:1045–55.
    1. Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001;103:2376–81.
    1. Erikssen G, Liestol K, Seem E, et al. Achievements in congenital heart defect surgery: a prospective, 40-year study of 7038 patients. Circulation 2015;131:337–46.
    1. Moons P, Bovijn L, Budts W, et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010;122:2264–72.
    1. Jortveit J, Oyen N, Leirgul E, et al. Trends in mortality of congenital heart defects. Congenit Heart Dis 2016;11:160–8.
    1. Mandalenakis Z, Rosengren A, Skoglund K, et al. Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 2017;177:224–30.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir